The US FDA on Thursday warned of ​a potentially high-risk issue involving ‌certain Edwards Lifesciences delivery systems used in transcatheter mitral valve replacement after ​one death and one serious ​injury.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in